Home » Javelin Pharmaceuticals Ends Deal With Myriad
Javelin Pharmaceuticals Ends Deal With Myriad
Javelin Pharmaceuticals is scuttling a deal to sell itself to Myriad Pharmaceuticals Inc., the company said Monday.
Seattle Times
Seattle Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May